These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12556084)

  • 1. Treatment with sevelamer decreases bicarbonate levels in peritoneal dialysis patients.
    Borràs M; Marco MP; Fernández E
    Perit Dial Int; 2002; 22(6):737-8. PubMed ID: 12556084
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients.
    Marco MP; Muray S; Betriu A; Craver L; Belart M; Fernández E
    Nephron; 2002 Oct; 92(2):499-500. PubMed ID: 12218343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyperphosphatemia with sevelamer in patients with chronic renal failure].
    Suñer M; Guerrero A; Montes R; Rivera M; Ruiz A; Martínez-García M; Pérez-Valdivia MA; Mateos J
    Nefrologia; 2004; 24(2):142-8. PubMed ID: 15219089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunity and cost of sevelamer in dialysis patients.
    Abderrhamane G; Renato D; Patrick F
    Kidney Int; 2005 Apr; 67(4):1636. PubMed ID: 15780128
    [No Abstract]   [Full Text] [Related]  

  • 5. Sevelamer-induced acidosis.
    Wrong OM; Harland CE
    Kidney Int; 2005 Feb; 67(2):776-7; author reply 777. PubMed ID: 15673330
    [No Abstract]   [Full Text] [Related]  

  • 6. Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications.
    Brezina B; Qunibi WY; Nolan CR
    Kidney Int Suppl; 2004 Sep; (90):S39-45. PubMed ID: 15296506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interaction between sevelamer and cyclosporin.
    Guillen-Anaya MA; Jadoul M
    Nephrol Dial Transplant; 2004 Feb; 19(2):515. PubMed ID: 14736993
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride.
    Sonikian MA; Pani IT; Iliopoulos AN; Koutala KG; Marioli SI; Vlassopoulos DA
    Ren Fail; 2005; 27(2):143-7. PubMed ID: 15807177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sevelamer hydrochloride: an effective phosphate binder in dialyzed children.
    Mahdavi H; Kuizon BD; Gales B; Wang HJ; Elashoff RM; Salusky IB
    Pediatr Nephrol; 2003 Dec; 18(12):1260-4. PubMed ID: 14586677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with sevelamer in peritoneal dialysis].
    Ortiz A; Ríos F; Melero R; Reyero A; Gazapo R; Casado S
    Nefrologia; 2003; 23(5):432-6. PubMed ID: 14658169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sevelamer: where are the data?
    McCarron DA
    Kidney Int; 2003 Dec; 64(6):2329; author reply 2329-30. PubMed ID: 14633168
    [No Abstract]   [Full Text] [Related]  

  • 12. Sevelamer hydrochloride in peritoneal dialysis patients: results of a multicenter cross-sectional study.
    Ramos R; Moreso F; Borras M; Ponz E; Buades JM; Teixidó J; Morey A; Garcia C; Vera M; Doñate MT; de Arellano MR; Barbosa F; González MT
    Perit Dial Int; 2007; 27(6):697-701. PubMed ID: 17984434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
    Sadek T; Mazouz H; Bahloul H; Oprisiu R; El Esper N; El Esper I; Boitte F; Brazier M; Moriniere P; Fournier A
    Nephrol Dial Transplant; 2003 Mar; 18(3):582-8. PubMed ID: 12584283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sevelamer, Ca x P product and vitamin D.
    Fournier A; Barsoum J; Fickl R; Oprisiu R; El Esper N; Moriniere P
    Nephrol Dial Transplant; 2001 Feb; 16(2):429-30. PubMed ID: 11158431
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic impact of sevelamer in patients with ESRD.
    Qunibi WY; Nolan CR
    Kidney Int; 2005 Apr; 67(4):1636-7. PubMed ID: 15780127
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium on trial: beyond a reasonable doubt?
    Nolan CR; Quinibi WY
    Kidney Int; 2003 Jan; 63(1):383; author reply 383-4. PubMed ID: 12472812
    [No Abstract]   [Full Text] [Related]  

  • 17. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
    Chertow GM; Burke SK; Raggi P;
    Kidney Int; 2002 Jul; 62(1):245-52. PubMed ID: 12081584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
    Pagé D; Knoll G
    Adv Perit Dial; 2005; 21():185-7. PubMed ID: 16686315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sevelamer.
    Henderson J; Altmann P
    Nephron Clin Pract; 2003; 94(3):c53-8. PubMed ID: 12902631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation.
    Pieper AK; Buhle F; Bauer S; Mai I; Budde K; Haffner D; Neumayer HH; Querfeld U
    Nephrol Dial Transplant; 2004 Oct; 19(10):2630-3. PubMed ID: 15304561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.